Understanding PAPA Syndrome: A Review of Its Characteristics
Author Information
Author(s): Elisabeth J. Smith, Florence Allantaz, Lynda Bennett, Dongping Zhang, Xiaochong Gao, Geryl Wood, Daniel L. Kastner, Marilynn Punaro, Ivona Aksentijevich, Virginia Pascual, Carol A. Wise
Primary Institution: Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Scottish Rite Hospital for Children, Dallas, Texas
Hypothesis
What are the clinical, molecular, and genetic characteristics of PAPA syndrome?
Conclusion
PAPA syndrome is characterized by mutations in the PSTPIP1 gene, leading to overproduction of IL-1β and significant clinical manifestations.
Supporting Evidence
- PAPA syndrome is caused by mutations in the PSTPIP1 gene.
- Overproduction of IL-1β is a key feature of PAPA syndrome.
- Anakinra, an IL-1 receptor antagonist, is effective in treating PAPA syndrome.
Takeaway
PAPA syndrome is a genetic condition that causes painful joint inflammation and skin problems due to a faulty gene. It can be treated with special medications that block a harmful protein.
Methodology
This review summarizes recent findings on the molecular aspects of PAPA syndrome and related disorders.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website